The current PE ratio of XNCR can't be determined, as the TTM EPS of -$2.19 is negative. The last PE ratio of Xencor, recorded in September 2022, was 48.11.
The PE ratio of Xencor has averaged 42.82 over the last eight years. In the past eight years, XNCR's PE ratio was at its highest in the Jun 2021 quarter at 86.23, when the stock price was $34.49 and the EPS was $0.4. The lowest value was in the Mar 2022 quarter, when it reached 14.27 with a price of $26.68 and an EPS of $1.87.
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | N/A | N/A |
| 2021 | 28.25 | N/A |
| 2020 | N/A | N/A |
| 2019 | 71.65 | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | 24.15 | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 10 | $367.43B |
| AMGN Amgen Inc | 45.32 | $171.14B |
| ABBV AbbVie Inc | 48.6 | $289.23B |
| MRK Merck & Co Inc | 144.76 | $333.65B |
| MGNX Macrogenics Inc | N/A | $295M |
| XNCR Xencor Inc | N/A | $1.31B |
The current price to earnings ratio of XNCR can't be calculated, as its EPS of -$2.19 is negative.
As an average over the last 3 years, XNCR stock has a PE ratio of 49.06.
As an average over the last 5 years, XNCR stock has a PE ratio of 52.19.
The highest quarterly PE ratio in the last eight years has been 86.23 and it was in the Jun 2021 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.